Profil
Mr. René Kurth is Senior Investment Director at Fonds de Solidarité FTQ.
Mr. Kurth was Portfolio Manager for the Agri-food, Metal Products and Life Sciences sectorsMr. Kurth was previously employed as a Portfolio Manager by BioCapital Investment Advisors, Inc. Mr. Kurth also served on the board at Biorthex, Inc, Premier Tech, de la Maison des Futailles, LJVH Holdings and Targanta Therapeutics, Inc. Mr. Kurth received his undergraduate degree from HEC Montréal.
René Kurth is also a Chartered Accountant (CA).
Postes actifs de René Kurth
| Sociétés | Poste | Début |
|---|---|---|
Licaplast Industries-Emballages, Inc.
Licaplast Industries-Emballages, Inc. Containers/PackagingProcess Industries Manufactures plastic bags | Directeur/Membre du Conseil | - |
Anciens postes connus de René Kurth
| Sociétés | Poste | Fin |
|---|---|---|
BioCapital Investment Advisors, Inc.
BioCapital Investment Advisors, Inc. Investment ManagersFinance The fundamental investment objective of BioCapital is to provide investors superior capital appreciation by investing in equity securities of public companies with high growth potential in biotechnology industries. They seek to achieve this fundamental objective by investing in a diversified portfolio of public companies primarily in the following sectors of the biotechnology industry: therapeutics in the fields of cancer, cardiology, infectious diseases, immune system and central nervous system. The firm also invests in companies developing platform technologies in the fields on genomics and proteomics, drug delivery, theranostics, nanotechnology and monoclonal antibody. | Gestionnaire de Portefeuille-Actions | 31/12/2005 |
Fonds de Solidarité FTQ
Fonds de Solidarité FTQ Investment ManagersFinance Fonds Régional de Solidarité FTQ invests in companies located in Canada, primarily in the Island of Montreal. The firm focuses on manufacturing, distribution, technology, real estate and service sectors. It provide equity or debt financing for growth stage capital requirements with an investment size of up to CAD 5 million and also it takes minority and control positions. | Private Equity Investor | - |
Biorthex, Inc.
Biorthex, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets surgical products | Directeur/Membre du Conseil | - |
Targanta Therapeutics, Inc.
Targanta Therapeutics, Inc. BiotechnologyHealth Technology Develops antibiotic drugs and other related products | Directeur/Membre du Conseil | - |
Formation de René Kurth
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Biorthex, Inc.
Biorthex, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets surgical products | Health Technology |
BioCapital Investment Advisors, Inc.
BioCapital Investment Advisors, Inc. Investment ManagersFinance The fundamental investment objective of BioCapital is to provide investors superior capital appreciation by investing in equity securities of public companies with high growth potential in biotechnology industries. They seek to achieve this fundamental objective by investing in a diversified portfolio of public companies primarily in the following sectors of the biotechnology industry: therapeutics in the fields of cancer, cardiology, infectious diseases, immune system and central nervous system. The firm also invests in companies developing platform technologies in the fields on genomics and proteomics, drug delivery, theranostics, nanotechnology and monoclonal antibody. | Finance |
Fonds de Solidarité FTQ
Fonds de Solidarité FTQ Investment ManagersFinance Fonds Régional de Solidarité FTQ invests in companies located in Canada, primarily in the Island of Montreal. The firm focuses on manufacturing, distribution, technology, real estate and service sectors. It provide equity or debt financing for growth stage capital requirements with an investment size of up to CAD 5 million and also it takes minority and control positions. | Finance |
Targanta Therapeutics, Inc.
Targanta Therapeutics, Inc. BiotechnologyHealth Technology Develops antibiotic drugs and other related products | Health Technology |
HEC Montréal
HEC Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Licaplast Industries-Emballages, Inc.
Licaplast Industries-Emballages, Inc. Containers/PackagingProcess Industries Manufactures plastic bags | Process Industries |
















